Conference abstract
Correlates of Covid-19 mortality in Bafoussam (Cameroon)
Pan African Medical Journal - Conference Proceedings. 2023:18(43).03
Oct 2023.
doi: 10.11604/pamj-cp.2023.18.43.1988
Archived on: 03 Oct 2023
Contact the corresponding author
Keywords: COVID-19, treatment, risk factors, mortality
Poster
Correlates of Covid-19 mortality in Bafoussam (Cameroon)
Jovanny Tsuala Fouogue1,&, Tankeu Happi Gilles Wilfrid1, Iliassou Mfopou2, Kenfack Bruno1, Enow Orock George3
1Université de Dschang, Dschang, Cameroun, 2Hopital Régional de Bafoussam, Bafoussam,Cameroun, 3Université de Buéa, Buéa, Cameroun
&Corresponding author
Introduction: identifying cases with higher mortality risk during epidemics is crucial in triage and resource allocation. During the COVID-19 epidemic, facts from early waves should underpin preventive measures and management algorithms for subsequent ones. Data on COVID-19 mortality are scarce in peripheral areas in Cameroon. The objective was to determine factors associated with death among hospitalized COVID-19 patients.
Methods: this was an analytical cross-sectional study of medical records of covid-19 patients hospitalized at the Bafoussam Regional Hospital. These were collected between March 16, 2020, and December 27, 2020. The factors associated with death from COVID-19 fell into several categories: demographic, clinical, biological, and therapeutic. They were studied using univariate and multivariate logistic regressions. Multicollinearity between the variables was studied to guide the construction of multivariate logistic models. Significance was set at the 5% threshold. RStudio software was used for statistical analysis.
Results: two hundred and fifty (250) cases were included. The median (IQR) age was 53 (28) years and 60.4% of patients were male. The following factors have significantly increased the risk of death: age ≥60 years (aOR:4.1; 95%CI:1.6 -11.4), smoking aOR:4.8; (95%CI: 1.1 - 21.6), sepsis (aOR: 4.2 (95%CI: 1.0 -19.7) and cardiac complications (aOR: 4.9; 95% CI: 1.1 - 24.0), abnormal fasting glycemia (aOR=5.9 [2.6; 14.8], p<0.001). Treatment with Azythromycin-Chloroquine reduced the risk of death (aOR=0.2; 95%CI: 0.1 - 0.5).
Conclusion: correlates of COVID-19 mortality in Bafoussam were similar to those reported elsewhere and treatment with azithromycin-chloroquine was protective.
Correlates of Covid-19 mortality in Bafoussam (Cameroon)
Jovanny Tsuala Fouogue1,&, Tankeu Happi Gilles Wilfrid1, Iliassou Mfopou2, Kenfack Bruno1, Enow Orock George3
1Université de Dschang, Dschang, Cameroun, 2Hopital Régional de Bafoussam, Bafoussam,Cameroun, 3Université de Buéa, Buéa, Cameroun
&Corresponding author
Introduction: identifying cases with higher mortality risk during epidemics is crucial in triage and resource allocation. During the COVID-19 epidemic, facts from early waves should underpin preventive measures and management algorithms for subsequent ones. Data on COVID-19 mortality are scarce in peripheral areas in Cameroon. The objective was to determine factors associated with death among hospitalized COVID-19 patients.
Methods: this was an analytical cross-sectional study of medical records of covid-19 patients hospitalized at the Bafoussam Regional Hospital. These were collected between March 16, 2020, and December 27, 2020. The factors associated with death from COVID-19 fell into several categories: demographic, clinical, biological, and therapeutic. They were studied using univariate and multivariate logistic regressions. Multicollinearity between the variables was studied to guide the construction of multivariate logistic models. Significance was set at the 5% threshold. RStudio software was used for statistical analysis.
Results: two hundred and fifty (250) cases were included. The median (IQR) age was 53 (28) years and 60.4% of patients were male. The following factors have significantly increased the risk of death: age ≥60 years (aOR:4.1; 95%CI:1.6 -11.4), smoking aOR:4.8; (95%CI: 1.1 - 21.6), sepsis (aOR: 4.2 (95%CI: 1.0 -19.7) and cardiac complications (aOR: 4.9; 95% CI: 1.1 - 24.0), abnormal fasting glycemia (aOR=5.9 [2.6; 14.8], p<0.001). Treatment with Azythromycin-Chloroquine reduced the risk of death (aOR=0.2; 95%CI: 0.1 - 0.5).
Conclusion: correlates of COVID-19 mortality in Bafoussam were similar to those reported elsewhere and treatment with azithromycin-chloroquine was protective.
